Henry Gosebruch

Henry Gosebruch is a Managing Director in J.P. Morgan’s Mergers & Acquisition Group. Mr. Gosebruch serves as Co-Head of Healthcare M&A with a focus on pharmaceuticals and biotech but has transaction expertise and client relationships across industries. Mr. Gosebruch also serves on J.P. Morgan’s fairness committee and as J.P. Morgan M&A engagements officer for North America.

Mr. Gosebruch is a German citizen and joined J.P. Morgan’s M&A Group in New York in 1995 as a graduate of the Wharton School of the University of Pennsylvania where he was a Benjamin Franklin Scholar. In October 2007, at age 34, he was selected by the New York Times for its Face Book of Wall Street’s Future listing 100 bankers, lawyers and investors. In September 2008, at age 35, he was selected by Dealmaker Magazine in its Top 40 Under 40. He has also been featured in the Financial Times and Bloomberg and has spoken at the Bloomberg Dealmaker Summit and the Reuters Healthcare Summit. Mr. Gosebruch has served on the faculty of the Practising Law Institute (PLi) regarding M&A  since 2010.

Mr. Gosebruch and his wife reside in New York City and have three sons.